In the other large group of 17x-alkyl-19-nor-testosterone derivatives, the progestational potency is influenced in all the cases when contrasted to the activity of 19-nortestosterone.
The most potent compounds in this line are represented by the 17a-ethyl and 17a-ethiny1-178-acetate. The 17a-ethiny1-45 (10) derivative is a weakly active compound which does not induce a complete progestational transformation of the rabbits endometrium.
The corresponding 3-deoxo-compounds of 17a-ethyl, 17ct-ethinyl and 17a-ally1-19-nortestosterone are less active as the 3-keto-steroids on subcutaneous and on oral administration, only the 17a-ethyl derivative retains the potency on oral administration when contrasted to the parent compound.
The basic activity of progesterone is increased about 3 times on subcutaneous administration in the retro 46-progesterone, the oral potency is more as 10 x progesterone, which is practically inactive on this route of administration.
A relationship between the pregnancy maintaining effect and chemical structure cannot be established, since only few compounds have been studied in this sense.
However, in this type of study a species difference is evident. There is no parallelism between the progestational activity assayed in the Clauberg test and the maintenance of pregnancy in spayed animals.
It has been shown that compounds so far studied will maintain pregnancy in spayed rats without oestrogens, when they exert a pituitary inhibiting effect. The exception is represented by the 17a-ethiny1-19-nor-testosterone and its 178-acetate . They will maintain pregnancy in the spayed rat for a short period of time only, it may be explained by the oestrogenic side effect of these compounds, which does not seem to be adequate in the sense of the progestagen : oestrogen ratio.
In some of the steroids described, a virilizing effect upon the female fetus has been reported in experiments, especially in the derivatives of androstane and 17a-alkyl-19-nor-testosterone. There is only one compound, the 6a-methy1-17a-hydroxyprogesterone17a-acetate deriving from the 17a-hydroxy-progesterone line which has virilizing properties in the rat. At the present time experimental studies are carried out which should help to clear this rather strange and diverse behaviour.
According to clinical studies a virilization of a female newborn has never been reported or observed.
In 898 cases with assumed 52% female babies studied in USA, no signs of virilization were observed. In Italy in 207 cases with 49% female babies the results are similar .
In Denmark, figures cannot be given, the survey revealed no signs of virilization in female babies whose mothers have been treated with 80mg/d the first, 40mg/d the second and 20mg/d the third week when submitted to the hospital for threatening abortion.
At the moment, according to our knowledge the transformation of the experimental data to men are doubtful ; at least have to be restricted. As far as the fertility control is concerned two models are used for experimental work, one is the rabbit. We do not Vol. 39 No. 6 believe that the rabbit is suitable for this type of work since the ovulation is always induced.
A model more adequate to the physiology of a rythmic ovulation is represented by the rat. In one of the most recent papers on this subject, a lack of the correlation between the inhibition of gonadotrophins in the parabiotic rat and the the inhibition of the ovulation was found in the rabbit. According to our experience there is always a correlation between these two parameters in the rat, although we would not like to exclude exceptions. These discrepancies may be explained in two ways, the one possibility is : the mode of action of the inhibition of ovulation is not yet established, some compounds may act directly on the ovary, others via the hypothalamic-hypophyseal axis and the rest both ways. The other explanation may be, that the response of an animal ovulating on stimulation only, may be diverse from the one in spontaneous and rhythmic ovulating species.
However in the rat, in our experience one may differentiate between inactive or poorly active pregnane-derivatives and the highly active steroids deriving from 17a-alkyl-l9-nor-testosterone. For the first group has to be mentioned one exception, the 6a-methyl-17a-hydroxyprogesterone-17a-acetate, whose activity is in the same range of the 17a-alkyl-l9-nor-testosterone derivatives. The 17a-ethinyl compound and its 17,Gacetate are very potent inhibitors of ovulation, less active is the 17a-ethiny1-45 (10) compound and the 17a-ethiny1-3-deoxo derivatives. All four of them exhibit an estrogenic activity which certainly enhances the inhibition of ovulation. The disadvantage of the two ethinyl-19-nor-compounds may be the androgenic side effect. Concluding our presentation one may state, that the relationship between the chemical structure and biological activity was established for the progestational and ovulation inhibiting potency. The maintenance of pregnany, due to species specificity and due to the rather complex condition, shows no signs of relationship at the present time.
